Claim 50% Off TipRanks Premium and Invest with Confidence
- Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis so your portfolio is always positioned for maximum potential
An update from Cannabist Company Holdings ( (TSE:CBST) ) is now available.
On December 18, 2025, The Cannabist Company agreed to sell all of the equity interests of its Virginia subsidiary, Green Leaf Medical of Virginia, which operates five active retail locations, one in development, and about 82,000 square feet of cultivation and production capacity in the Richmond area, to Parma Holdco LLC, an affiliate of Millstreet Credit Fund LP, for $130 million in cash consideration, subject to customary adjustments and escrow arrangements; the deal, which does not require shareholder approval but remains contingent on regulatory and other closing conditions, is expected to close in early 2026, with a portion of the proceeds earmarked to redeem outstanding senior secured notes. The transaction emerged from a go-shop process overseen by a special committee amid operational and financial pressures on the company and the wider cannabis industry, leading Cannabist on December 18, 2025 to terminate a previously signed December 1, 2025 sale agreement with Curaleaf after determining the Millstreet-backed proposal to be superior, a shift that advances its broader strategic review but also obliges the company to pay Curaleaf a $3.3 million break-up fee.
The most recent analyst rating on (TSE:CBST) stock is a Sell with a C$0.52 price target. To see the full list of analyst forecasts on Cannabist Company Holdings stock, see the TSE:CBST Stock Forecast page.
Spark’s Take on TSE:CBST Stock
According to Spark, TipRanks’ AI Analyst, TSE:CBST is a Underperform.
Cannabist Company Holdings is facing severe financial difficulties, with declining revenues, high leverage, and negative equity. The technical analysis indicates an overbought condition without clear momentum, and the valuation reflects unprofitability. These factors contribute to a low overall stock score.
To see Spark’s full report on TSE:CBST stock, click here.
More about Cannabist Company Holdings
The Cannabist Company Holdings, formerly Columbia Care, is a U.S. multi-state cannabis operator that cultivates, manufactures and retails cannabis products across medical and adult-use markets. With licenses in 12 U.S. jurisdictions, it runs 77 facilities, including 61 dispensaries and 16 cultivation and manufacturing sites, and offers a portfolio spanning flower, edibles, oils and tablets under brands such as dreamt, Seed & Strain, Triple Seven, Hedy, gLeaf, Classix, Press and Amber, anchored by its Cannabist retail network launched in 2021.
Technical Sentiment Signal: Sell
Current Market Cap: C$227.8M
Find detailed analytics on CBST stock on TipRanks’ Stock Analysis page.